Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Adoptive cell therapy for solid tumours

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.10.17
Views: 1549
Rating:

Dr Sophie Papa - Guy's Hospital, London, UK

Dr Papa speaks with ecancer at the ACP immunotherapy workshop about genetically modified immune cells as a treatment choice for solid tumours.

She highlights the successes of using tumour-infiltrating lymphocyte to treat a small subset of melanoma patients, and how engineered CAR T cells are 'heating up' tumours which had previously been non-immunogenic.

By comparison to haematological malignancies, Dr Papa considers the challenges in treating solid tumours with systemic therapies,

Related videos

18.06.19

no rating
Cancer care in Latin America

follow us

Donate to ecancer


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation